PIPELINE

We are currently evaluating the immunogenicity and efficacy of Hiltonol® (PICLC) alone, with vaccines or with immune costimulators over a variety of indications in Phase I and II clinical trials.  (See clinicaltrials.gov for a complete list)

Hiltonol® Collaborative Clinical Trials by Indication (see clinicaltrials.gov for a complete list)

# of Phase I/II Clinical Trials

© 2019 by Oncovir, Inc.    Terms of Use

  • Twitter